Centene Is Maintained at Buy by Truist Securities
Barclays Maintains Overweight on Centene, Raises Price Target to $93
Centene Is Maintained at Outperform by Oppenheimer
Wells Fargo Maintains Centene(CNC.US) With Buy Rating, Raises Target Price to $76
Oppenheimer Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $85
A Quick Look at Today's Ratings for Centene(CNC.US), With a Forecast Between $73 to $93
Oppenheimer Reaffirms Their Buy Rating on Centene (CNC)
Analysts Are Bullish on These Healthcare Stocks: Medios AG (MEDOF), Centene (CNC)
Centene Raised to Buy From Neutral by UBS
Stephens Cuts Price Target on Centene to $73 From $75, Keeps Equalweight Rating
Truist Securities Adjusts Price Target on Centene to $84 From $89
Centene Analyst Ratings
Centene's Undervaluation and Strategic Growth Positions: A Buy Recommendation by A.J. Rice
Cantor Fitzgerald Reiterates Overweight on Centene, Maintains $90 Price Target
Barclays Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $91
Centene (CNC) Receives a Buy From Barclays
Centene Price Target Cut to $52.00/Share From $68.00 by Jefferies
Centene Analyst Ratings
Jefferies Downgrades Centene(CNC.US) to Sell Rating, Cuts Target Price to $52
Deutsche Bank Maintains Centene(CNC.US) With Hold Rating, Cuts Target Price to $84